Pathophysiology of aplastic anaemia.
It is the conventional opinion that acquired aplastic anaemia is a heterogenous disease including basically different conditions, such as idiopathic or virus induced pancytopenia, toxic-allergic marrow damage or autoimmunity. Here, an alternative concept is proposed, according to which aplastic anaemia is one disease, but multifactorial in all patients, apparent differences being due to the relative prevalence of one or the other pathophysiological component in individual patients. Bone marrow from patients in the severe phase of aplastic anaemia does not grow in culture and is therefore not suitable for experimentation. Alternatively, bone marrow from patients who have resumed some degree of autologous bone marrow function, but still have residual signs of the disease after non-invasive therapy, offers the possibility to study pathophysiological mechanisms in vitro. The majority of experiments presented in this chapter have been done in such patients, assuming that their status of disease in some way reflects the original, more serious pretreatment condition. Three major pathophysiological components will be discussed, and it will be proposed how these factors act in concert to cause or aggravate aplasia.
Nissen-Druey
C
C
Zentrum für Lehre und forschung, Kantonsspital, Abt Hamatologie, Basel, Switzerland.
D000741:Anemia, Aplastic / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D015551:Autoimmunity; D003114:Colony-Forming Units Assay; D006413:Hematopoietic System / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D006801:Humans